In vitro permeability through caco-2 cells is not quantitatively predictive of in vivo absorption for peptide-like drugs absorbed via the dipeptide transporter system.
Data up to Jan 2025
Total Citations Per Year
Abstract
References (16)
Characterization of the Human Colon Carcinoma Cell Line (Caco-2) as a Model System for Intestinal Epithelial Permeability
1989 • 2,127 citations
Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells
1991 • 1,787 citations
Enterocyte-like differentiation and polarization of the human colon carcinoma cell line Caco-2 in culture
1983 • 1,765 citations
Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability
1989 • 1,027 citations
Uptake of the cephalosporin, cephalexin, by a dipeptide transport carrier in the human intestinal cell line, Caco-2
1990 • 224 citations
Association of Intestinal Peptide Transport with a Protein Related to the Cadherin Superfamily
1994 • 182 citations
Disposition of pravastatin sodium, a tissue‐selective HMG‐CoA reductase inhibitor, in healthy subjects.
1990 • 174 citations
Transepithelial transport of oral cephalosporins by monolayers of intestinal epithelial cell line Caco-2: specific transport systems in apical and basolateral membranes.
1992 • 150 citations
Antimicrobial Activity and Human Pharmacology of Amoxicillin
1974 • 112 citations
ABSORPTION OF CAFFEINE FROM TEA, COFFEE, AND COCA COLA
1973 • 89 citations
Intestinal Absorption Mechanism of Dipeptide Angiotensin Converting Enzyme Inhibitors of the Lysyl-Proline Type: Lisinopril and SQ 29,852
1989 • 79 citations
Angiotensin‐converting enzyme (ACE) inhibitor transport in human intestinal epithelial (Caco‐2) cells
1995 • 78 citations
Metabolic Studies in Patients with Nadolol: Oral and Intravenous Administration
1977 • 76 citations
Lisinopril: A New Angiotensin-Converting Enzyme Inhibitor
1988 • 42 citations
Disposition of 14C-guanabenz in patients with essential hypertension*
1980 • 28 citations
Cephalexin: Pharmacologic Evaluation Following Oral and Parenteral Administration
1973 • 8 citations